Suchergebnisse - (Subject:"angiotensin-converting enzyme inhibitors")

PubPharm (387)

81

Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization : results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study

enthalten in: American heart journal | 2009

von Bi, Y. | Gao, R. | Patel, A. | +80

82

Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers : results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study

enthalten in: American heart journal | 2009

von Cesari, M. | Kritchevsky, S. | Atkinson, H. | +4

83

Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle

enthalten in: American heart journal | 2009

von Hsu, D. | Mital, S. | Ravishankar, C. | +89

84

Erythropoietin levels in heart failure after an acute myocardial infarction : determinants, prognostic value, and the effects of captopril versus losartan

enthalten in: American heart journal | 2009

von Belonje, A. | Westenbrink, B. | Voors, A. | +5

85

Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension

enthalten in: American heart journal | 2008

von Napoli, C. | Bruzzese, G. | Ignarro, L. | +9

86

Re : Gender disparity in cardiac procedures and medication use for acute myocardial infarction

enthalten in: American heart journal | 2008

von Ramaraj, R.

CommentOn: Am Heart J. 2008 May;155(5):862-8. - PMID 18440333

87

Determining the most appropriate components for a composite clinical trial outcome

enthalten in: American heart journal | 2008

von Bethel, M. | Holman, R. | Haffner, S. | +4

88

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance : rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

enthalten in: American heart journal | 2008

von Califf, R. | Boolell, M. | Haffner, S. | +69

89

Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction : an INternational VErapamil SR-Trandolapril (INVEST) substudy

enthalten in: American heart journal | 2008

von Bangalore, S. | Messerli, F. | Cohen, J. | +8

90

Should an angiotensin-converting enzyme inhibitor be given at the time of reperfusion therapy in acute myocardial infarction?

enthalten in: American heart journal | 2008

von McLachlan, C. | Ocsan, R. | Hambly, B. | +1

CommentOn: Am Heart J. 2008 Feb;155(2):388-94. - PMID 18215613